Zydus Lifesciences Ltd.
BSE: 532321 | NSE: ZYDUSLIFE
Mid Cap | Pharmaceuticals & Drugs
936.35
-6.20 (-0.66%) Zydus Lifesciences - Quaterly Results
Date: 20-05-2022
A minor change in the total revenue was seen in the March 2022 quarter. The total revenue for the quarter stood at Rs. 20193.00 millions against Rs. 20084.00 millions during year ago period.Profit after Tax for the quarter ended March 2022 saw a decline of -46.87% from Rs. 4647.00 millions to Rs. 2469.00 millions.The Operating Profit of the company witnessed a decrease to 5113.00 millions from 5773.00 millions.
(Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202203 | 202103 | % Var | 202203 | 202103 | % Var | 202203 | 202103 | % Var | |
| Sales | 20193.00 | 20084.00 | 0.54 | 79819.00 | 77800.00 | 2.60 | 79819.00 | 77800.00 | 2.60 |
| Other Income | 537.00 | -165.00 | -425.45 | 1787.00 | 893.00 | 100.11 | 1787.00 | 893.00 | 100.11 |
| PBIDT | 5113.00 | 5773.00 | -11.43 | 20968.00 | 23980.00 | -12.56 | 20968.00 | 23980.00 | -12.56 |
| Interest | 420.00 | 205.00 | 104.88 | 1349.00 | 709.00 | 90.27 | 1349.00 | 709.00 | 90.27 |
| PBDT | 4693.00 | 5568.00 | -15.71 | 16426.00 | 21396.00 | -23.23 | 16426.00 | 21396.00 | -23.23 |
| Depreciation | 1228.00 | 1150.00 | 6.78 | 4787.00 | 4511.00 | 6.12 | 4787.00 | 4511.00 | 6.12 |
| PBT | 3465.00 | 4418.00 | -21.57 | 11639.00 | 16885.00 | -31.07 | 11639.00 | 16885.00 | -31.07 |
| TAX | 996.00 | -229.00 | -534.93 | 3060.00 | 2123.00 | 44.14 | 3060.00 | 2123.00 | 44.14 |
| Deferred Tax | 217.00 | -784.00 | -127.68 | 458.00 | -910.00 | -150.33 | 458.00 | -910.00 | -150.33 |
| PAT | 2469.00 | 4647.00 | -46.87 | 8579.00 | 14762.00 | -41.88 | 8579.00 | 14762.00 | -41.88 |
| Equity | 1024.00 | 1024.00 | 0.00 | 1024.00 | 1024.00 | 0.00 | 1024.00 | 1024.00 | 0.00 |
| PBIDTM(%) | 25.32 | 28.74 | -11.91 | 26.27 | 30.82 | -14.77 | 26.27 | 30.82 | -14.77 |